Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
ROONEY, CLIONA
One or more keywords matched the following items that are connected to ROONEY, CLIONA
Item TypeName
Academic Article New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Academic Article Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection.
Academic Article Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma.
Academic Article Differential activation of cytotoxic responses by Burkitt's lymphoma (BL)-cell lines: relationship to the BL-cell surface phenotype.
Academic Article Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Academic Article Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.
Academic Article Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
Academic Article Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.
Academic Article Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.
Academic Article Donor T cells to treat EBV-associated lymphoma.
Academic Article Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease.
Academic Article Epstein-Barr infection after bone marrow transplantation.
Academic Article Adoptive cellular immunotherapy for EBV lymphoproliferative disease.
Academic Article Cytotoxic T cells and immunotherapy.
Academic Article EBV specific CTL: a model for immune therapy.
Academic Article Immunotherapy for Epstein-Barr virus-associated cancers.
Academic Article Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection.
Academic Article Gene and cell transfer for specific immunotherapy.
Academic Article Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.
Academic Article Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.
Academic Article Use of gene marking in bone marrow transplantation.
Academic Article Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation.
Academic Article Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines.
Academic Article Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.
Academic Article Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.
Academic Article Immunotherapy for Hodgkin's disease.
Academic Article Targeting CD19 with genetically modified EBV-specific human T lymphocytes.
Academic Article The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses.
Academic Article The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study.
Academic Article An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.
Academic Article The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients.
Academic Article Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells.
Academic Article A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.
Academic Article CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.
Academic Article Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.
Academic Article Post-transplant lymphoproliferative disorders.
Academic Article Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.
Academic Article Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.
Academic Article Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.
Academic Article Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.
Academic Article Transfection and gene expression in normal and malignant primary B lymphocytes.
Academic Article Immune therapy for EBV infections after hemopoietic stem-cell transplant.
Academic Article Immunotherapy for Epstein-Barr virus-associated cancers in children.
Academic Article Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
Academic Article The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.
Academic Article Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor.
Academic Article Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
Academic Article Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.
Academic Article Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.
Academic Article Targeted delivery of adenoviral vectors by cytotoxic T cells.
Academic Article Options for T-cell based therapies.
Academic Article Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease.
Academic Article A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors.
Academic Article Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors.
Academic Article Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.
Academic Article Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Academic Article Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
Academic Article Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease.
Academic Article Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.
Academic Article Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.
Academic Article Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
Academic Article Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Academic Article Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.
Academic Article The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.
Academic Article Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
Academic Article Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).
Academic Article T cell therapies.
Academic Article Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
Academic Article Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.
Academic Article Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.
Academic Article Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.
Academic Article Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).
Academic Article Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.
Academic Article Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.
Academic Article Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.
Academic Article Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.
Academic Article PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.
Academic Article Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.
Academic Article Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.
Academic Article Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
Academic Article EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.
Academic Article Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma.
Academic Article Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.
Academic Article Endemic and sporadic cases of Epstein-Barr virus-positive Burkitt's lymphoma: immunological characterization of derived cell lines.
Academic Article Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance.
Academic Article Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
Academic Article Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
Academic Article Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
Academic Article Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity.
Academic Article Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.
Academic Article Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.
Academic Article Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.
Academic Article Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.
Academic Article Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.
Academic Article Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes.
Academic Article Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.
Academic Article Prompt versus preemptive intervention for EBV lymphoproliferative disease.
Academic Article Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
Academic Article In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
Academic Article Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
Academic Article Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12.
Academic Article Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
Academic Article Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function.
Academic Article Structure and function of the Epstein-Barr virus BZLF1 protein.
Academic Article Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.
Academic Article Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.
Academic Article Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant.
Academic Article Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses.
Concept Cytomegalovirus Infections
Concept Herpesvirus 6, Human
Concept Cytomegalovirus
Concept Herpesvirus 4, Human
Concept Herpesvirus 3, Human
Academic Article Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.
Academic Article Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
Academic Article Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
Academic Article T lymphocytes targeting native receptors.
Academic Article Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
Academic Article Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.
Academic Article Reply to S. Yuan et al.
Academic Article Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.
Academic Article CMV-specific T cells generated from na?ve T cells recognize atypical epitopes and may be protective in vivo.
Academic Article Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency.
Academic Article Adoptive T-Cell Immunotherapy.
Academic Article EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas.
Academic Article HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Academic Article Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
Academic Article Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.
Academic Article Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo.
Academic Article Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
Grant CYTOTOXIC T CELL TRANSFER FOR THERAPY OF EBV LYMPHOMA
Academic Article EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
Academic Article T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.
Academic Article T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells.
Academic Article Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.
Academic Article Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Academic Article Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo.
Academic Article A Costimulatory CAR Improves TCR-based Cancer Immunotherapy.
Academic Article Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy.
Academic Article Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells.
Search Criteria
  • Cytomegalovirus